Circulating tumor DNA: current challenges for clinical utility is a research paper published in Journal of Clinical Investigation (2022). On theSindex it has a DataRank of 0.805. It has been cited 213 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.805
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 2U54CA163072-12
(2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities
National Institutes of Health
Grant: 5T32CA119925-10
Integrated Biological Systems Training in Oncology
NCI NIH HHS
Grant: R01 CA194024
NCI NIH HHS
Grant: P50 CA098131
NCI NIH HHS
Grant: P30 CA068485
NCI NIH HHS
Grant: R01 CA214494
NCI NIH HHS
Grant: U54 CA163072
NCI NIH HHS
Grant: T32 CA119925
Influential Citations
7
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals